Guardant Health has a total of 460 patents globally, out of which 131 have been granted. Of these 460 patents, more than 84% patents are active. The United States of America is where Guardant Health has filed the maximum number of patents, followed by Europe and China. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Guardant Health.
Guardant Health was founded in the year 2012. Guardant Health is a business that deals with biotechnology. For cancer patients, the company offers sequencing and cell testing services. As of March 2023, Guardant Health has a market cap of $2.42 Billion.
Do read about some of the most popular patents of Guardant Health which have been covered by us in this article and also you can find Guardant Health patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Guardant Health patent portfolio.
How many patents does the founder and the CEO of Guardant Health have?
The founder AmirAli Talasaz, Helmy Eltoukhy (Also CEO) have 189, 151 patents.
How many patents does Guardant Health have?
Guardant Health has a total of 460 patents globally. These patents belong to 91 unique patent families. Out of 460 patents, 390 patents are active.
How Many Patents did Guardant Health File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Guardant Health Applications Filed | Guardant Health Patents Granted |
| 2023 | – | 4 |
| 2022 | 25 | 25 |
| 2021 | 65 | 35 |
| 2020 | 53 | 38 |
| 2019 | 87 | 12 |
| 2018 | 39 | 7 |
| 2017 | 61 | 5 |
| 2016 | 41 | – |
| 2015 | 24 | 2 |
| 2014 | 26 | – |
| 2013 | 36 | 1 |
| 2012 | 1 | – |
How many Guardant Health patents are Alive/Dead?
How Many Patents did Guardant Health File in Different Countries?
Countries in which Guardant Health Filed Patents
| Country | Patents |
| United States Of America | 146 |
| Europe | 62 |
| China | 36 |
| Canada | 27 |
| Australia | 20 |
| Singapore | 18 |
| Germany | 15 |
| Korea (South) | 14 |
| Spain | 14 |
| Hong Kong (S.A.R.) | 13 |
| United Kingdom | 4 |
| Israel | 4 |
| Brazil | 3 |
| Norway | 3 |
| Mexico | 3 |
| India | 2 |
| Italy | 2 |
| Poland | 2 |
| Denmark | 1 |
| Portugal | 1 |
Where are Research Centres of Guardant Health Patents Located?
10 Best Guardant Health Patents
WO2014039556A1 is the most popular patent in the Guardant Health portfolio. It has received 270 citations so far from companies like Agilome, Sequenom and Karius.
Below is the list of 10 most cited patents of Guardant Health:
| Publication Number | Citation Count |
| WO2014039556A1 | 270 |
| US9598731B2 | 224 |
| WO2015100427A1 | 221 |
| US20140066317A1 | 188 |
| WO2017181146A1 | 144 |
| US7700286B2 | 110 |
| WO2018009723A1 | 108 |
| USRE44596E1 | 81 |
| US20160040229A1 | 77 |
| US9834822B2 | 74 |
How many inventions of other companies were rejected due to Guardant Health patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Guardant Health invention. They couldn’t because Guardant Health had protected those before them.
Examiners at the USPTO referred 21 Guardant Health patents in 31 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Guardant Health patent portfolio are Natera, Grail and Travera.
List of the Companies whose Patents were rejected citing Guardant Health –
| Company | Number of Patent Applications that faced Rejection Citing Guardant Health Patents | Number of Rejections (102 & 103) |
| Natera | 5 | 5 |
| Grail | 2 | 4 |
| Travera | 1 | 1 |
| Philips | 1 | 1 |
| Samsung | 1 | 2 |
| IBM | 1 | 3 |
| Nantomics | 1 | 1 |
| Insybio | 1 | 3 |
| Personal Genome Diagnostics | 1 | 2 |
| Karius | 1 | 2 |
Count of 102 and 103 Type Rejections based on Guardant Health Patents
